Preclinically, in a post-stroke depression rat model, intranasal delivery of a BDNF-encoding adeno-associated viral vector (AAV-BDNF) increased BDNF mRNA and protein in the prefrontal cortex, alleviating depressive-like symptoms [190]. The gene discussed is BDNF; the disease is stroke disorder.